SMTL ID : 6qh9.1 (1 other biounit)

Crystal Structure of Human Kallikrein 6 in complex with GSK3239861A

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.27 Å

Oligo State

monomer

Ligands

1 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)

UNX.1: 1 residues within 4Å: Chain A: H.23 No protein-ligand interaction detected (PLIP)

1 x J2N: (3~{S})-~{N}-(4-carbamimidoylphenyl)-2-oxidanylidene-piperidine-3-carboxamide(Non-covalent)

J2N.2: 18 residues within 4Å: Chain A: L.25, C.26, H.41, D.170, S.171, C.172, Q.173, G.174, D.175, S.176, V.190, W.192, G.193, N.194, I.195, C.197, G.204 Ligands: J3B.3 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.190, A:I.195, A:I.195 Hydrogen bonds: A:L.25, A:D.170, A:D.170, A:G.174, A:D.175, A:S.176, A:S.176, A:S.176 Water bridges: A:N.194, A:V.205

1 x J3B: (3~{R})-~{N}-(4-carbamimidoylphenyl)-2-oxidanylidene-piperidine-3-carboxamide(Non-covalent)

J3B.3: 17 residues within 4Å: Chain A: L.25, C.26, D.170, S.171, C.172, Q.173, G.174, D.175, S.176, V.190, W.192, G.193, N.194, I.195, C.197, G.204 Ligands: J2N.2 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.190, A:I.195, A:I.195 Hydrogen bonds: A:L.25, A:D.170, A:D.170, A:G.174, A:D.175, A:S.176, A:S.176, A:S.176 Water bridges: A:N.194, A:V.205

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

White, G.V. et al., Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome. Bioorg. Med. Chem. Lett. (2019)

Release Date

2019-02-06

Peptides

Kallikrein-6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Kallikrein-6

Related Entries With Identical Sequence